Studies have revealed that TMAO promoted vascular endothelial cell inflammation and advanced atherosclerosis by increasing the expression of the nuclear-factor kappa B (NF-κB), nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3, IL-1β, and IL-18 [25, 72]. This evidence concerns the gene IL1B and atherosclerosis.